volume 99, issue 3, P454-461 1997
DOI: 10.1542/peds.99.3.454
View full text
W. J. Rodriguez, W. C. Gruber, R. C. Welliver, J. R. Groothuis, E. A. F. Simoes, H. C. Meissner, V. G. Hemming, C. B. Hall, M. L. Lepow, A. J. Rosas, C. Robertsen, A. A. Kramer

Abstract: RSVIG treatment was safe but not efficacious in the treatment of children with bronchopulmonary dysplasia, congenital heart disease, or premature gestation who were hospitalized with RSV LRI.